Clients News • MC Services corporate website
5522
page-template-default,page,page-id-5522,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.7.0,vc_responsive

CLIENT NEWS

 

 

  • Newron announces Half-Year 2021 results
    16 September 2021
    www.newron.com
  • Temedica develops new digital companion Brisa for people with multiple sclerosis in cooperation with Roche
    14 September 2021
    www.temedica.com
  • Abivax provides an update on the ABX464 clinical data and development strategy in ulcerative colitis
    14 September 2021
    www.relieftherapeutics.com
  • RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval
    13 September 2021
    www.redhillbio.com
  • Adocia To Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
    10 September 2021
    www.adocia.com
  • Marinomed Biotech AG publishes clinical data on efficacy of Carragelose lozenges against respiratory viruses including SARS-CoV-2 in the International Journal of General Medicine
    09 September 2021
    www.marinomed.com
  • EsoCap – unique targeted application platform to treat the upper gastrointestinal tract
    09 September 2021
    www.esocapbiotech.ch
  • InflaRx to Proceed with Pivotal Development for Vilobelimab in Hidradenitis Suppurativa with New Primary Endpoint
    08 September 2021
    www.inflarx.de
  • Diaccurate Acquires Clinical Stage Sole-in-Class Targeted Cancer Therapy from Merck
    08 September 2021
    www.diaccurate.com
  • XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab
    08 September 2021
    www.xphyto.com